CYP11A1 expression identifies anaphylaxis risk in children with peanut allergy March 5, 2018 No Comments
Bristol-Myers Squibb presents phase Ib data for anti-PD-L1 BMS-936559 in sepsis March 1, 2018 No Comments
DS-28120313 shows in vivo efficacy as a potent orally active hepcidin production inhibitor Dec. 13, 2017 No Comments
Bristol-Myers Squibb initiates phase I trial of BMS-986235 in healthy subjects Nov. 24, 2017 No Comments
RSS